Recombinant expression and characterization of novel P450s from Actinosynnema mirum.

Bioorg Med Chem

Chair for Bioprocess Engineering, Department of Biochemical and Chemical Engineering, TU Dortmund University, Emil-Figge-Straße 66, 44227 Dortmund, Germany. Electronic address:

Published: July 2021

Cytochrome P450 monooxygenases (P450s) are the major contributor in the metabolism of xenobiotics, including therapeutic agents. Thus, P450s find broad application in the pharmaceutical industry to synthesize metabolites of new active pharmaceutical ingredients in order to evaluate toxicity and pharmacokinetics. As an alternative to human hepatic P450s, microbial P450s offer several advantages, such as an easier and more efficient heterologous expression as well as higher stability under process conditions. Recently, the wild-type strain Actinosynnema mirum has been reported to catalyze hydroxylation reactions with high activity on a broad range of substrates. In this study, one of these substrates, ritonavir, was used to analyze the transcriptional response of the wild-type strain. Analysis of the differential gene expression pattern allowed the assignment of genes potentially responsible for ritonavir conversion. Heterologous expression of these candidates and activity testing led to the identification of a novel P450 that efficiently converts ritonavir resembling the activity of the human CYP3A4.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2021.116241DOI Listing

Publication Analysis

Top Keywords

actinosynnema mirum
8
heterologous expression
8
wild-type strain
8
p450s
5
recombinant expression
4
expression characterization
4
characterization novel
4
novel p450s
4
p450s actinosynnema
4
mirum cytochrome
4

Similar Publications

Article Synopsis
  • Shinorine is a UV-protective compound used in cosmetics and pharmaceuticals, but scaling up its production industrially has been challenging despite the creation of modified strains.
  • The study introduced specific genes into a strain named DXdT to enhance the conversion of sedoheptulose 7-phosphate into mycosporine-glycine, a precursor for shinorine, and then used a new ligase to produce shinorine.
  • The engineered strain achieved significant yields of shinorine using lignocellulosic byproducts, demonstrating the potential for sustainable production from agricultural waste materials.
View Article and Find Full Text PDF

Sedoheptulose 7-phosphate (SH7P) cyclases are a subset of sugar phosphate cyclases that are known to catalyze the first committed step in many biosynthetic pathways in primary and secondary metabolism. Among them are 2--5--valiolone synthase (EEVS) and 2--valiolone synthase (EVS), two closely related SH7P cyclases that catalyze the conversion of SH7P to 2--5--valiolone and 2--valiolone, respectively. However, how these two homologous enzymes use a common substrate to produce stereochemically different products is unknown.

View Article and Find Full Text PDF

Sustainable Production of Shinorine from Lignocellulosic Biomass by Metabolically Engineered .

J Agric Food Chem

December 2022

Department of Integrative Food, Bioscience and Biotechnology, Chonnam National University, Gwangju 61186, Republic of Korea.

Mycosporine-like amino acids (MAAs) have been used in cosmetics and pharmaceuticals. The purpose of this work was to develop yeast strains for sustainable and economical production of MAAs, especially shinorine. First, genes involved in MAA biosynthetic pathway from were introduced into for heterologous shinorine production.

View Article and Find Full Text PDF

Recombinant expression and characterization of novel P450s from Actinosynnema mirum.

Bioorg Med Chem

July 2021

Chair for Bioprocess Engineering, Department of Biochemical and Chemical Engineering, TU Dortmund University, Emil-Figge-Straße 66, 44227 Dortmund, Germany. Electronic address:

Cytochrome P450 monooxygenases (P450s) are the major contributor in the metabolism of xenobiotics, including therapeutic agents. Thus, P450s find broad application in the pharmaceutical industry to synthesize metabolites of new active pharmaceutical ingredients in order to evaluate toxicity and pharmacokinetics. As an alternative to human hepatic P450s, microbial P450s offer several advantages, such as an easier and more efficient heterologous expression as well as higher stability under process conditions.

View Article and Find Full Text PDF

Genome-Guided Discovery of Pretilactam from ATCC 31565.

Molecules

June 2019

NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

is a small but well-known genus of actinomycetes for production of ansamitocin, the payload component of antibody-drug conjugates against cancers. However, the secondary metabolite production profile of ATCC 31565, the most famous producer of ansamitocin, has never been fully explored. Our antiSMASH analysis of the genomic DNA of ATCC 31565 revealed a NRPS-PKS gene cluster for polyene macrolactam.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!